Day One Biopharmaceuticals, Inc.
DAWN$972M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaBRISBANE184 employees
Drugs in Pipeline
2
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
DAWN News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Chemotherapeutic Agent | Phase 3 | Low-grade Glioma | - | - |
Tovorafenib | Phase 3 | Low-grade Glioma | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply